Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05958368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes

Study acronym: AVOCADO-T2D
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later May 30, 2026 → Nov 30, 2026
See other at-risk trials from Pennington Biomedical Research Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from May 30, 2026 to Nov 30, 2026
    • Enrollment closed, study ongoing
    • Eligibility criteria expanded, about 30 words
    • Site details revised
  2. Primary completion date: Jun 30, 2025 to May 30, 2026
    • Study completion date: Dec 15, 2025 to Dec 15, 2026
    v7
  3. Re-verified, no change to tracked fieldsv6
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2, 2023 to Oct 10, 2023
    v5
  5. Start date: Sep 15, 2023 to Oct 2, 2023v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jul 31, 2023 to Sep 15, 2023v3
  2. Interventions: Dietary (Other) to Avocado (Other), Other Fruit(s) (Other)
    • Secondary endpoints: details revised at 3 of 3 entries
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.
Trial Details
NCT Number NCT05958368
Lead Sponsor Pennington Biomedical Research Center
Collaborators: Prachi Singh, Frank L. Greenway, Robbie A. Beyl
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2, Insulin, Fructosamine, C-Reactive Protein, Glucose, Overweight and Obesity
Related terms Diabetes Mellitus, Type 2, Insulin Resistance, Obesity, Overweight
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov